Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
SAIC-Frederick Will Integrate Geospiza Software with PacBio Sequencing for Cancer Research
The collaboration is part of NCI's Advanced Technology Partnerships Initiative, which "seeks to reduce the time and cost of developing new cancer treatments," according to a statement
New to GenomeWeb? Register quickly here.